BBG: Buyout giant CVC seeking more than €1 billion in Amsterdam IPO
BLOOMBERG reports: – Private equity firm may target up to €15 billion valuation – CVC has been ...
THE WALL STREET JOURNAL reports:
Johnson & Johnson is poised to begin a roadshow to pitch shares of its consumer-healthcare business, the producer of household names such as Tylenol, in a test for an IPO market that has been in the doldrums for the past year.
Kenvue Inc. plans to start meeting with prospective investors as early as Monday, people familiar with the matter said. The goal is to raise $3.5 billion or more in the offering at a valuation close to $40 billion, the people said. IPO roadshows typically last anywhere from a few days to a week ahead of the stock’s trading debut…
The full post is here.
FAK rate hikes holding, with strong demand into peak season predicted
DSV could face $16m bill after helicopter is written off in haulage accident
Déjà vu as major ocean carriers scramble for tonnage and containers
Indian trade disrupted as port congestion forces liner services to skip calls
Trade growth getting stronger, but ocean freight rates stay flattish
Rising costs of port congestion force surcharge by Asian feeder operators
Global airfreight volumes blooming as flower shipments take off
Comment on this article